Skip to content

MDMA: all studies

Page 110 of 347: studies 1,091 to 1,100 of 3,461, newest first. Back to the MDMA overview

Research

Inhibition of 3,4-methylenedioxymethamphetamine metabolism leads to marked decrease in 3,4-dihydroxymethamphetamine formation but no change in serotonin neurotoxicity: implications for mechanisms of neurotoxicity.

Synapse October 2011 Melanie Mueller, Jie Yuan, Concepcion Maldonado Adrian et al.

3,4-Methylenedioxymethamphetamine (MDMA)'s O-demethylenated metabolite, 3,4-dihydroxymethamphetamine (HHMA), has been hypothesized to serve as a precursor for the formation of toxic catechol-thioether metabolites (e.g., 5-N-acetylcystein-S-yl-HHMA) that mediate MDMA neurotoxicity. To further test this hypothesis, HHMA formation was blocked with dextromethorphan (DXM), which competitively...

MDMA: interactions with other psychoactive drugs.

Pharmacology, Biochemistry, and Behavior October 2011 Wael M.Y. Mohamed, Sami Ben Hamida, Jean-Christophe Cassel et al.

3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) is one of the most widely abused illegal drugs. Some users self-report euphoria and an increased perception and feeling of closeness to others. When taken in warm environments, MDMA users may develop acute complications with potential fatal consequences. In rodents, MDMA increases locomotor activity and, depending on ambient temperature, may...

Self‐administered MDMA produces dose‐ and time‐dependent serotonin deficits in the rat brain

Addiction Biology September 28, 2011 Jennifer Do, Susan Schenk 37 citations

ABSTRACT 3,4‐Methylenedioxymethamphetamine (MDMA) use and abuse have been increasing worldwide. Of concern, exposure to high doses of MDMA decreases several markers of serotonin (5HT) neurotransmission and produces deficits in tissue levels of 5HT. Studies in laboratory animals have been conducted primarily following large doses (20.0–80.0 mg/kg) of experimenter‐administered MDMA, but it is...

MDMA (ecstasy) effects on actual driving performance before and after sleep deprivation, as function of dose and concentration in blood and oral fluid

Psychopharmacology September 27, 2011 Wendy M. Bosker, Kim P. C. Kuypers, Silke Conen et al. 32 citations

RATIONALE: Experimental research has shown that 3,4-methylenedioxymethamphetamine (MDMA) can improve some psychomotor driving skills when administered during the day. In real life, however, MDMA is taken during the night, and driving may likely occur early in the morning after a night of "raving" and sleep loss. OBJECTIVES: The present study assessed the effects of MDMA on road-tracking and...

Long‐lasting neuroprotective effect of sildenafil against 3,4‐methylenedioxymethamphetamine‐ induced 5‐hydroxytryptamine deficits in the rat brain

Journal of Neuroscience Research September 21, 2011 Elena Puerta, Lucía Barros-Miñones, Isabel Hervias et al. 17 citations

Sildenafil, given shortly before 3,4-methylenedioxymethamphetamine (MDMA), affords protection against 5-hydroxytryptamine (5-HT) depletions caused by this amphetamine derivative by an acute preconditioning-like mechanism. Because acute and delayed preconditionings do not share the same mechanisms, we investigated whether sildenafil would also protect the 5-HT system of the rat if given 24 hr...

Pills and pints: Risky drinking and alcohol‐related harms among regular ecstasy users in Australia

Drug and Alcohol Review September 15, 2011 Stuart A. Kinner, Jessica George, Jennifer M. Johnston et al. 19 citations

INTRODUCTION AND AIMS: A significant proportion of young Australians engage in risky alcohol consumption, and an increasing minority are regular ecstasy (3,4-methylenedioxymethamphetamine) users. Risky alcohol use, alone or in combination with ecstasy, is associated with a range of acute and chronic health risks. The aim of this study was to document the incidence and some health-related...

The relationships of ‘ecstasy’ (MDMA) and cannabis use to impaired executive inhibition and access to semantic long‐term memory

Human Psychopharmacology Clinical and Experimental September 7, 2011 Philip N. Murphy, Philip G. Erwin, L. Maciver et al. 9 citations

This study aimed to examine the relationship between the consumption of ecstasy (3,4-methylenedioxymethamphetamine (MDMA)) and cannabis, and performance on the random letter generation task which generates dependent variables drawing upon executive inhibition and access to semantic long-term memory (LTM). The participant group was a between-participant independent variable with users of both...

( )-3,4-Methylenedioxymethamphetamine and Metabolite Disposition in Plasma and Striatum of Wild-Type and Multidrug Resistance Protein 1a Knock-Out Mice

Journal of Analytical Toxicology September 1, 2011 Karl B. Scheidweiler, Bruce Ladenheim, Allan J. Barnes et al. 10 citations

Mice lacking multidrug resistance protein 1a (mdr1a) are protected from methylenedioxymethamphetamine (MDMA)-induced neurotoxicity, suggesting mdr1a might play an important role in this phenomenon. We characterized MDMA pharmacokinetics in murine plasma and brain to determine if mdr1a alters MDMA distribution. Wild-type (mdr1a⁺/⁺) and mdr1a knock-out (mdr1a⁻/⁻) mice received i.p. 10, 20 or 40...

MDMA (ecstasy) enhances loud noise-induced morphofunctional alterations in heart and adrenal gland.

Microscopy research and technique September 2011 Federica Fulceri, Michela Ferrucci, Paola Lenzi et al.

Noise is an environmental stressor increasingly more present in modern life and, in particular, in a variety of recreational contexts. The aim of this work is to show the effects of noise on the myocardium and adrenal gland, through a careful review of the literature dealing with the peripheral effects of noise exposure in experimental and clinical studies. Noise induces adverse effects in...

DOI: 10.1002/jemt.20971 (opens in new tab) Full text (opens in new tab) Amphetamine derivatives Catecholamine Environmental stress Myocardium +1

Influences of activity wheel access on the body temperature response to MDMA and methamphetamine.

Pharmacology, Biochemistry, and Behavior September 2011 N W Gilpin, M J Wright, G Dickinson et al.

Recreational ingestion of the drug 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") can result in pathologically elevated body temperature and even death in humans. Such incidents are relatively rare which makes it difficult to identify the relative contributions of specific environmental and situational factors. Although animal models have been used to explore several aspects of...